Syndax Pharmaceuticals Inc (SNDX) has 72 open-market insider trades by 14 insiders since 2016. Over the last six months insiders net sold $152K. The most active filer is Michael A. Metzger, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Briggs Morrison | Dir | — | 17 | $26.9M | 2024-02-07 |
| Michael A. Metzger | CEO | — | 19 | $11.9M | 2026-07-08 |
| Peter Ordentlich | CSO | — | 8 | $3.5M | 2023-02-15 |
| Pierre Legault | Dir | — | 3 | $2.5M | 2026-02-04 |
| Dennis Podlesak | Dir | — | 2 | $2.3M | 2026-02-04 |
| Ivor Royston | Dir | — | 1 | $1.8M | 2017-03-20 |
| Fabrice Egros | Dir | — | 4 | $968K | 2022-02-02 |
| Keith Katkin | Dir | — | 3 | $939K | 2026-02-04 |
| Keith A. Goldan | CFO | — | 7 | $304K | 2026-06-01 |
| Nicholas A.j. Botwood | CMO | — | 1 | $106K | 2026-06-12 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Michael A. Metzger | CEO | Sell | $785K | 2026-07-08 |
| Nicholas A.j. Botwood | CMO | Sell | $1.2M | 2026-06-11 |
| Keith A. Goldan | CFO | Sell | $22K | 2026-06-01 |
| Michael A. Metzger | CEO | Sell | $130K | 2026-06-01 |
| Michael A. Metzger | CEO | Sell | $361K | 2026-02-09 |
| Keith A. Goldan | CFO | Sell | $72K | 2026-02-09 |
Companies that share insiders with SNDX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Michael A. Metzger | CEO | Sell | $153K | 2026-02-06 |
| Keith A. Goldan | CFO | Sell | $43K | 2026-02-06 |
| Michael A. Metzger | CEO | Sell | $5.2M | 2025-09-08 |
| Dennis Podlesak | Director | Sell | $875K | 2025-08-14 |
| Keith A. Goldan | CFO | Sell | $12K | 2025-07-16 |
| Michael A. Metzger | CEO | Sell | $140K | 2025-07-16 |
| Keith Katkin | Director | Buy | $91K | 2025-05-19 |
| Martin H. Huber Jr. | Director | Buy | $45K | 2025-05-19 |
| Nicholas A.j. Botwood | CMO | Buy | $106K | 2025-05-16 |